Pulse Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-35.4M | $-35.8M | $441.0K | $10.1M |
| FY2021 | $-54.1M | $-54.5M | $437.0K | $14.6M |
| FY2022 | $-47.0M | $-47.4M | $401.0K | $5.2M |
| FY2023 | $-33.0M | $-33.2M | $121.0K | $7.2M |
| FY2024 | $-36.3M | $-36.5M | $125.0K | $13.6M |